Znanstveni rad - Izvorni znanstveni rad
A single-arm, open-label study to assess the immunogenicity, safety, and efficacy of etanercept manufactured using the serum-free, high-capacity manufacturing process administered to patients with rheumatoid arthritis
European Journal of Rheumatology, 6 (2019), 1; 23-28. https://doi.org/10.5152/eurjrheum.2018.18078

Polak, Pavol; Perić, Porin; Louw, Ingrid; Gaylord, Stefanie M.; Williams, Theresa; Becker, Jean-Claude; Pedersen, Ron; Korth-Bradley, Joan; Vlahos, Bonnie

Citirajte ovaj rad

Polak, P., Perić, P., Louw, I., Gaylord, S. M., Williams, T., Becker, J. C. ... Vlahos, B. (2019). A single-arm, open-label study to assess the immunogenicity, safety, and efficacy of etanercept manufactured using the serum-free, high-capacity manufacturing process administered to patients with rheumatoid arthritis. European Journal of Rheumatology, 6. (1), 23-28. doi: 10.5152/eurjrheum.2018.18078

Polak, Pavol, et al. "A single-arm, open-label study to assess the immunogenicity, safety, and efficacy of etanercept manufactured using the serum-free, high-capacity manufacturing process administered to patients with rheumatoid arthritis." European Journal of Rheumatology, vol. 6, br. 1, 2019, str. 23-28. https://doi.org/10.5152/eurjrheum.2018.18078

Polak, Pavol, Porin Perić, Ingrid Louw, Stefanie M. Gaylord, Theresa Williams, Jean Claude Becker, Ron Pedersen, Joan Korth Bradley i Bonnie Vlahos. "A single-arm, open-label study to assess the immunogenicity, safety, and efficacy of etanercept manufactured using the serum-free, high-capacity manufacturing process administered to patients with rheumatoid arthritis." European Journal of Rheumatology 6, br. 1 (2019): 23-28. https://doi.org/10.5152/eurjrheum.2018.18078

Polak, P., et al. (2019) 'A single-arm, open-label study to assess the immunogenicity, safety, and efficacy of etanercept manufactured using the serum-free, high-capacity manufacturing process administered to patients with rheumatoid arthritis', European Journal of Rheumatology, 6(1), str. 23-28. doi: 10.5152/eurjrheum.2018.18078

Polak P, Perić P, Louw I, Gaylord SM, Williams T, Becker JC, i sur.. A single-arm, open-label study to assess the immunogenicity, safety, and efficacy of etanercept manufactured using the serum-free, high-capacity manufacturing process administered to patients with rheumatoid arthritis. European Journal of Rheumatology [Internet]. 01.2019. [pristupljeno 21.07.2024.];6(1):23-28. doi: 10.5152/eurjrheum.2018.18078

P. Polak, et al., "A single-arm, open-label study to assess the immunogenicity, safety, and efficacy of etanercept manufactured using the serum-free, high-capacity manufacturing process administered to patients with rheumatoid arthritis", European Journal of Rheumatology, vol. 6, br. 1, str. 23-28, Siječanj 2019. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:030476. [Citirano: 21.07.2024.]